HAP/VAP care bundle interventions - a UK approach. Dr R G Masterton NHS Ayrshire & Arran

Similar documents
The Clinical Management of Hospital Acquired Pneumonia. NHS Ayrshire & Arran

Guess or get it right?

VAP Prevention bundles

Targeted literature review:

Sepsis. Reliability- can we achieve Dr Ron Daniels

Potential Conflicts of Interests

Moving from VAP to VAC

Ventilator Associated Pneumonia Vap

Quality Improvement: Why and How. Michael L. Rinke, MD March 9 th, 2013

Quality & Safety Committee Date: 22 June 2016 Agenda item: 4.4

convey the clinical quality measure's title, number, owner/developer and contact

Ventilator Associated

Sepsis: What Is It Really?

Ayrshire and Arran NHS Board

Improving Prevention and Control of Infection Quarter 2 Report: April 2009 September 2009

HEALTHCARE-ASSOCIATED PNEUMONIA: DIAGNOSIS, TREATMENT & PREVENTION

Bundle Therapy in Critical Care

Diagnosis of Ventilator- Associated Pneumonia: Where are we now?

Saving Lives: Focusing on Severe Sepsis and Septic Shock

Superhero or Superzero? Vancomycin vs. Linezolid for MRSA Pneumonia

The Infection Control Doctor and Clostridium difficile infection. Dr David R Jenkins University Hospitals of Leicester NHS Trust, England

Introduction. Centers for Disease Control and Prevention (CDC),

Aneurin Bevan Health Board. Quarterly Infection Control Report

New Strategies in the Management of Patients with Severe Sepsis

MAKING SENSE OF IT ALL AUGUST 17

Prescribe appropriate immunizations for. Prescribe childhood immunization as per. Prescribe influenza vaccinations in high-risk

Naeem Ali, MD Medical Director. The Ohio State University Wexner Medical Center

Last frontier of infection in critically ill patients

American College of Surgeons Critical Care Review Course 2012: Infection Control

ANWICU knowledge

NHS GRAMPIAN. Healthcare Associated Infection (HAI) Bimonthly Report January 2017

Nothing to disclose 9/25/2017

9/25/2017. Nothing to disclose

Stressed Out: Evaluating the Need for Stress Ulcer Prophylaxis in the ICU

Guidelines 2017 for the management of hospitalacquired pneumonia (HAP) and. ventilator-associated. pneumonia (VAP)

Journey to Decreasing Clostridium Difficile and the Unexpected Twist. Jackie Morton, Infection Prevention Cortney Swiggart, Medication Safety Officer

The Sepsis Timebomb. James Wigfull Critical Care and Anaesthesia Sheffield Teaching Hospitals

Care Guideline DRAFT for review cycle 08/02/17 CARE OF THE ADULT PNEUMONIA PATIENT

CURRENT GUIDELINES FOR SEPSIS MANAGEMENT

Current Concepts in VAP: Stress Ulcer Prophylaxis & Probiotics. Deborah Cook

Venous Thromboembolism (VTE) Prevention and Treatment of VTE in Patients Admitted to Hospital

Preventing Ventilator-Associated Pneumonia: Five Components of Care

CARE OF THE ADULT PNEUMONIA PATIENT

Think Globally: Strategies to Improve the Culture of Antibiotic Prescribing

EFFECT OF EARLY VASOPRESSIN VS NOREPINEPHRINE ON KIDNEY FAILURE IN PATIENTS WITH SEPTIC SHOCK. Alexandria Rydz

The past. The evolving role of epidemiology in infection prevention and control: past present and future. Overview. Epidemiology

Intracheal antibiotics administration

No conflicts of interest to disclose

A Snapshot of Colistin Use in South-East Europe and Particularly in Greece

Rapid Response Teams. January 17, Safe Table Webinar

Sepsis Update: Focus on Early Recognition and Intervention. Disclosures

UPDATE IN HOSPITAL MEDICINE

Outline. Pharmacists Improving Outcomes in the Management of. of Infectious Diseases. Threats Against Desired Outcomes 7/11/2010

Sepsis 3.0: The Impact on Quality Improvement Programs

Optimizing Antibiotic Therapy in the ICU For Pneumonia Current and Future Approaches

Pharmacologyonline 1: (2010) ewsletter Singh and Kochbar. Optimizing Pharmacokinetic/Pharmacodynamics Principles & Role of

MT Custom Weaning Protocol for your Ventilator Patients SMARTCARE /PS

Healthcare Associated Infection Report February 2016 data

Ayrshire and Arran NHS Board

MDR AGENTS: RISK FACTORS AND THERAPEUTIC STRATEGIES

Implementation and evaluation of the impact of a "ventilator-bundle at Kinshasa University Clinics: Before and after study.

Linezolid for treatment of ventilator-associated pneumonia: a cost-effective alternative to vancomycin Shorr A F, Susla G M, Kollef M H

Continuous Infusion of Antibiotics In The ICU: What Is Proven? Professor of Medicine Vice-Chairman, Department of Medicine SUNY at Stony Brook

Sepsis in primary care. Sarah Bailey, Emma Evans, Nicola Shoebridge, Fiona Wells

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016

Surveillance of Surgical Site Infection Annual Report For procedures carried out from: January December 2009

GUIDE TO INFECTION CONTROL IN THE HOSPITAL. Carbapenem-resistant Enterobacteriaceae

Community Acquired Pneumonia. Background & Rationale to North American Guidelines. Lionel Mandell MD FRCPC Brussels Belgium

MT Custom Weaning Protocol for your Ventilator Patients SMARTCARE /PS

ENGLISH FOR PROFESSIONAL PURPOSES UNIT 3 HOW TO DEAL WITH CLOSTRIDIUM DIFFICILE

Further information You can get more information and share your experience at

Do PPIs Reduce Bleeding in ICU? Revisiting Stress Ulcer Prophylaxis. Deborah Cook

HEALTHCARE-ASSOCIATED PNEUMONIA: EPIDEMIOLOGY, MICROBIOLOGY & PATHOPHYSIOLOGY

Cardiology Department. Clinical Governance

Contraindications to time critical surgery; when not to proceed from the perspective of: The Physician A/Prof Peter Morley

Sepsis Management Update 2014

Key Points. Angus DC: Crit Care Med 29:1303, 2001

Surviving Sepsis Campaign. Guidelines for Management of Severe Sepsis/Septic Shock. An Overview

MALDI-TOF MS: Translating Microbiology Laboratory Alphabet Soup to Optimize Antibiotic Therapy

Skin and soft tissue (SSTI) sepsis (surgery, antimicrobial therapy and more)

Surviving Sepsis Campaign Guidelines 2012 & Update for David E. Tannehill, DO Critical Care Medicine Mercy Hospital St.

NO DISCLOSURES 5/9/2015

Doc: 1.9. Course: Patient Safety Solutions. Topic: Infection prevention and control. Summary

Educational Workshop

ESCMID Online Lecture Library. by author

Falls Prevention and Management in Scotland: the Impact of Local and National Policies

Sepsis Management: Past, Present, and Future

2016 Sepsis Update: Pearls, Pitfalls, and Core Measure Quicksand

The Ever Changing World of Sepsis Management. Laura Evans MD MSc Medical Director of Critical Care Bellevue Hospital

A real journey. Using The Model For Improvement To Reduce Falls and Injury

LAPAROSCOPIC RADICAL REMOVAL OF THE KIDNEY INFORMATION FOR PATIENTS

HOSPITAL INFECTION CONTROL

CPD Matrix for Intensive Care Medicine

Aminoglycosides as an antibiotic class maintain

BC Sepsis Network Emergency Department Sepsis Guidelines

Andrea Blotsky MDCM FRCPC General Internal Medicine, McGill University Thursday, October 15, 2015

KICU Spontaneous Awakening Trial (SAT) Questionnaire

ACCP/SCCM Critical Care Preparatory Review and Recertification Course Learning Objectives

GOVERNING BODY MEETING in Public 22 February 2017 Agenda Item 3.4

Transcription:

HAP/VAP care bundle interventions - a UK approach Dr R G Masterton NHS Ayrshire & Arran

How Hazardous Is Health Care? (Leape and Amalberti) Total lives lost per year 100,000 10,000 1,000 100 10 1 HAZARDOUS (>1/1000) Health Care Mountain Climbing Bungee Jumping REGULATED Driving Chemical Manufacturing Chartered Flights Scheduled Airlines 1 10 100 1,000 10,000 100,000 1,000,00 0 Number of encounters for each fatality ULTRA-SAFE (<1/100K) European Railroads Nuclear Power 10,000,0 00

Healthcare Quality Strategy 3 Quality Ambitions Mutually beneficial partnerships between patients, their families and those delivering healthcare services. Partnerships which respect individual needs and values and which demonstrate compassion, continuity, clear communication and shared decision-making. No avoidable injury or harm from the healthcare they receive, and that they are cared for in an appropriate, clean and safe environment at all times. The most appropriate treatments, interventions, support and services will be provided at the right time to everyone who will benefit, with no wasteful or harmful variation.

Healthcare Quality Strategy 3 Quality Ambitions Mutually beneficial partnerships between patients, their families and those delivering healthcare services. Partnerships which Person respect centred individual needs and values and which demonstrate compassion, continuity, clear communication and shared decision-making. No avoidable injury or harm from the healthcare they receive, and that they are Harm cared for in an appropriate, clean and safe environment at all times. The most appropriate treatments, interventions, support and services will be provided at the right time to everyone who will benefit, with no wasteful or harmful variation. Waste & Variation

Quality Measurement Framework Quality Outcome Measures HEAT Supporting local and national quality indicators

Healthcare Quality & Cost QUALITY INITIATIVES COST REDUCTION PROGRAMMES 3 1 2 3 4 5 Costs more Cost neutral Improves quality Quality neutral Reduces quality reduces costs

To do things differently, we must see things differently. When we see things we haven t noticed before, we can ask questions we didn t know to ask before. John Kelsch, Xerox Quality Health care in America Project

Care Bundle

HAP Guideline Recommendations Grade Prevention Diagnosis Treatment A 11 5 5 B 10 0 6 C 9 5 3 D 8 2 3 GPP 60 6 10 Masterton et al. J Antimicrob Chemother. 2008;62:5-34.

HAP Guideline Recommendations Grade Prevention Diagnosis Treatment A 11 5 5 B 10 0 6 C 9 5 3 D 8 2 3 GPP 60 6 10 Masterton et al. J Antimicrob Chemother. 2008;62:5-34.

What is a Care Bundle? 1. Set of around 5 evidence-based interventions that apply to all patients with a common disease. 2. Ensure the delivery system means the interventions are delivered. 3. Compliance is all or nothing. 4. Measure outcomes to ascertain benefits. 5. Develop the will to deliver all the time every time. Masterton. Intensive Care Med. 2009;35:1149-51.

Success of Care Bundles in Healthcare Environment Institute of Healthcare Improvement 100K Lives Campaign in USA has now become the 5 Million Lives Campaign Care Bundles demonstrated to be highly effective: Central Line Bundle has reduced bloodstream infections Ventilator Bundle has reduced ventilator associated pneumonia Care Bundles to prevent HCAI are advocated High Impact Interventions in the Department of Health Saving Lives delivery programme Seven Care Bundles published to date: Most for insertion/care of indwelling catheters/devices Care Bundle for prevention of spread of Clostridium Difficile includes an element for prudent antibiotic prescribing

Severe Sepsis Bundles Bundle use = consistent and significant improvement in survival Antibiotic administration, timing and appropriateness = maximum outcome benefit. Khan et al. Indian J Crit Care Med. 2010 ;14: 8 13

The New Treatment Paradigm VAP Care Bundle Antimicrobial Care Bundle

THE NEW TREATMENT PARADIGM

The New Treatment Paradigm Start with the appropriate empiric antibiotic first in nosocomial infections If appropriate, change antibiotic dosage or therapy based on resistance and pathogen information Recognise that prior antimicrobial administration is a risk factor for the presence of resistant pathogens Know the unit s resistance profile and choose antibiotics accordingly Administer antibiotics at the right dose for the appropriate duration Masterton. Int J Antimicrob Agents. 2009 ;33:105-110.

Getting it right Improved survival rate (%) 50 43 40 30 20 23 20 10 0 Septic shock Severe shock Sepsis Rello et al. Crit Care Med 2003;31:2807 2808

The Clock is ticking Survivial (%) 90 80 70 60 50 40 30 20 10 0 Each hour off delay carries 7.6% reduction in survival 0.5 1 2 3 4 5 6 Delay in treatment (hours) from hypotension onset Kumar et al. Crit Care Med 2006; 34:1589-1596.

The New Paradigm in a Care Bundle Secondary analysis of prospective before after study Intervention: emergency department sepsis bundle Bundle components Patient identification Fluid resuscitation Vasopressor administration Antibiotic recommendations Shorr, et al. Crit Care Med 2007;35:1257 1262

The New Paradigm in a Care Bundle 100 000 Total group 80 000 Survivors 80 000 60 000 Cost per patient (US $) 60 000 40 000 20 000 0 p=0.009 Total cost (US $) 40 000 20 000 0 Before Before After Group Mortality reduced with protocol from 48.3% to 30.0% (p=0.04) Group After Shorr, et al. Crit Care Med 2007;35:1257 1262

The New Paradigm in a Care Bundle 2,000 Before After 1,600 Costs (US$ x 1000) 1,200 800 Total cost differential: $573,000 400 0 Total ICU Ward Pharmacy Lab Rad RT ED OR Misc Shorr, et al. Crit Care Med 2007;35:1257 1262

The New Paradigm in a Care Bundle 1.0 Proportion of subjects remaining hospitalised 0.8 0.6 0.4 0.2 Pre-intervention Post-intervention p=0.0023 Median LOS Pre: 10 days Post: 7.5 days 0.0 0 10 20 30 40 Length of stay (days) Shorr, et al. Crit Care Med 2007;35:1257 1262

VAP CARE BUNDLE

The Care Bundle Approach VAP Care Bundle 5 simple, basic, universally accepted components Bed elevation Sedation vacation Daily weaning assessment Peptic ulcer prophylaxis DVT prophylaxis Craven. Chest;2006;130:251-260

VAP Care Bundle The Top Ten Empiric therapy based on knowledge of local pathogens and assessment of risk factors Immediate treatment following microbiological sampling Oral care with chlorhexadine Non invasive ventilation preferred SD for mechanically ventilated patients greater than 48 hours Assess response within 72 hours Short duration of treatment therapy - 8 days if patient on appropriate regimen and not infected by MDR pathogen Sedation vacation and weaning protocol Monotherapy in preference to combination therapy in those not at risk for pseudomonas or MDR De-escalate in responding patients once culture results available Prevention Diagnosis Treatment 600 620 640 660 680 700 720 Rello et al. J Crit Care. 2010 May 26. [Epub ahead of print] & Intensive Care Med. 2010;36:773-80.

VAP Care Bundle Treatment Empiric therapy based on knowledge or local pathogens and assessment of risk factors Immediate treatment following microbiological sampling Assess response within 72 hours Short duration of treatment therapy - 8 days if patient on appropriate regimen and not infected by MDR pathogen Monotherapy in preference to combination therapy in those not at risk for pseudomonas or MDR De-escalate in responding patients once culture results are available 600 620 640 660 680 700 720 Rello et al. J Crit Care. 2010 May 26. [Epub ahead of print] & Intensive Care Med. 2010;36:773-80.

Impact of IHI VAP Improvement Bundle The key components of the Ventilator Bundle are: 1. Elevation of the Head of the Bed 2. Daily "Sedation Vacations" and Assessment of Readiness to Extubate 3. Peptic Ulcer Disease Prophylaxis 4. Deep Venous Thrombosis Prophylaxis 5. Daily Oral Care with Chlorhexidine Al-Tawfiq et al. Am J Infect Control. 2010 Apr 17. [Epub ahead of print].

Impact of IHI VAP Improvement Bundle VAP prevention bundle resulted in reduction of VAP rates from (P <.001) : Mean of 9.3 cases/1000 ventilator-d in 2006 Mean of 2.3 cases/1000 ventilator-d in 2007 Mean of 2.2 cases/1000 ventilator-d in 2008 Each VAP case increased: attributable hospital LoS by 10 days mean hospital cost by $40,000. Al-Tawfiq et al. Am J Infect Control. 2010 Apr 17. [Epub ahead of print].

VAP Care Bundle in The Ayr Hospital 1. Elevation of the Head of the Bed to 30 2. Daily Sedation Break 3. Discussion of Extubation and Weaning 4. Daily x4 Oral Care with Chlorhexidine Al-Tawfiq et al. Am J Infect Control. 2010 Apr 17. [Epub ahead of print].

VAP in The Ayr Hospital

VAP in The Ayr Hospital

ANTIMICROBIAL CARE BUNDLE

The Antimicrobial Care Bundle At initiation: Document clinical rationale for antibiotic initiation Appropriate specimens sent to diagnostic microbiology laboratory (according to local policy) Antibiotic selected according to local policy and risk group (exclude allergy) Consider removal of foreign body/drainage of pus/surgical intervention Cooke et al. Int J Antimicrob Agents. 2007;30: 25 29.

The Antimicrobial Care Bundle For continuation: Daily consideration of: de-escalation intravenous oral switch stopping antibiotics (based on review of clinical picture and laboratory results) Antibiotic drug levels monitored as required by local policy Cooke et al. Int J Antimicrob Agents. 2007;30: 25 29.

The Antimicrobial Stewardship Bundle Documentation of treatment rationale Collection of appropriate specimens Appropriate empirical selection of antibiotics according to local surveillance and formulary De-escalation Selection of appropriate agents for definitive therapy Toth et al. American Journal of Health-System Pharmacy, 2010;67: 746-749.

The Antimicrobial Stewardship Bundle A total of 160 patients and 442 antibiotic orders were evaluated. 168 interventions were made, with an acceptance rate of 91%. De-escalation rose from 72% to 90% (p = 0.01). Compliance with all quality indicators rose from 16% to 43% (p < 0.001). Toth et al. American Journal of Health-System Pharmacy, 2010;67: 746-749.

Success Through Education The Change Team Bloos et al. British Journal of Anaesthesia 2009;103: 232 7.

Success Through Education The Change Team No difference in VAP frequency Audit I (33.1%) and Audit II (32.4%, P=0.68). Bloos et al. British Journal of Anaesthesia 2009;103: 232 7.

Success Through Feedback The Electronic Dashboard Zaydfudim et al. Arch Surg. 2009;144(7):656-662.

Success Through Feedback The Electronic Dashboard Zaydfudim et al. Arch Surg. 2009;144(7):656-662.

Success Through Feedback The Electronic Dashboard Zaydfudim et al. Arch Surg. 2009;144(7):656-662.

Success Through MMP The Multimodal Programme VAP prevention bundle compliance increased after active implementation. VAP incidence fell significantly from 19.2 to 7.5 per 1,000 ventilator days. Rate difference (99% CI) = 11.6 (2.3-21.0) per 1,000 ventilator days; Rate ratio (99% CI) = 0.39 (0.16, 0.96). Multimodal programme = staff education, process measurement, outcome measurement, feedback to staff and organisational change. Hawe et al. Intensive Care Med. 2009;35:1180-6.

Success Through the IHI Tool The Model for Improvement When you combine the 3 questions with the What are we trying to accomplish? How will we know that a change is an improvement? What change can we make that will result in improvement? PDSA cycle, you get Act Study Plan Do the Model for Improvement